SCHEMBL8730951

SCHEMBL8730951

CCCOC(=O)c1ccccc1OCC[C]=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
ADRB2 P07550 1/20 0.54
ADRB1 P08588 1/20 0.54
ADRB3 P13945 1/20 0.54
TSHR P16473 6/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP3A4 P08684 3/20 0.49
MAPK1 P28482 2/20 0.49
TP53 P04637 1/20 0.49
LMNA P02545 4/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
NR1I2 O75469 1/20 0.47
CHRM2 P08172 1/20 0.47
ADRA2A P08913 1/20 0.47
OPRK1 P41145 1/20 0.47
HTR2B P41595 1/20 0.47
SLC6A3 Q01959 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2949387 0.88 ALDH1A1 (0.73) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL27881214 0.85 TSHR (0.70) ALDH1A1ADRB2ADRB1ADRB3TSHR
Bicarbonate SCHEMBL5184161 0.85 ALDH1A1 (0.69) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL1073658 0.83 ALDH1A1 (0.71) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL11427520 0.81 TSHR (0.73) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL5157954 0.81 ALDH1A1 (0.67) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL9969538 0.80 TSHR (0.65) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL975212 0.80 TSHR (0.77) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL524955 0.80 ALDH1A1 (0.61) ALDH1A1ADRB2ADRB1ADRB3TSHR
SCHEMBL8730957 0.80 ALDH1A1 (0.61) ALDH1A1ADRB2ADRB1ADRB3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998043649-A2 AGE PRODUCTION INHIBITORY COMPOSITION COMPRISING A MAILLARD REACTION INHIBITOR AND VITAMIN B¿6? OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-10-08 WO disclosed
US-5422360-A Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-06-06 US disclosed
EP-0531812-A1 Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 EP disclosed